查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2009401

周边动脉疾病市场规模、份额、趋势和预测：按类型、最终用户和地区划分，2026-2034 年

Peripheral Artery Disease Market Size, Share, Trends and Forecast by Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2025年全球周边动脉疾病市场规模为51亿美元。预计到2034年，该市场规模将达到79亿美元，2026年至2034年的复合年增长率（CAGR）为4.78%。目前，北美市场主导地位，2025年市占率达39.1%。推动市场成长的主要因素包括人口老化、诊断和治疗领域的各种技术创新、居家照护环境的扩展以及医疗基础设施的改善。此外，人们生活水准的提高也促进了周边动脉疾病市场份额的成长。

目前，由于糖尿病和高胆固醇症等慢性疾病的盛行率不断上升，显着增加了周边动脉疾病的风险，因此该市场正在成长。老年人口的成长，尤其是那些更容易患循环系统疾病的老年人，也是推动市场扩张的因素。患者和医疗专业人员意识的提高，使得诊断更加迅速，治疗更加及时。此外，影像学和微创技术的创新正在改善治疗效果，使更多患者能够接受治疗。新药疗法的研发进一步加强了疾病管理和症状控制。医疗保健支出的成长以及都市区地区医疗服务可近性的提高，也是推动周边动脉疾病市场成长的因素。

由于多种因素，美国正崛起为周边动脉疾病市场的重要区域。糖尿病、肥胖、高血压和吸烟等文明病的高发生率是周边动脉疾病的重要诱因，推动了该市场的稳定成长。根据美国疾病管制与预防中心（CDC）的数据显示，2010年至2024年间，美国成年人的肥胖率增加了13.6%。人口老化导致血管疾病易感人群数量增加，进一步刺激了市场需求。美国拥有完善的医疗保健基础设施，支援早期诊断、先进影像技术和微创治疗方案。药物研发和医疗设备的不断进步正在改善治疗效果并减少併发症。

周边动脉疾病市场趋势：

微创手术的技术进步

先进的导管医疗设备和技术的发展正在革新血管介入治疗，为传统开放性手术提供了微创替代方案。这些进步显着改善了治疗效果，减轻了患者的不适感，缩短了住院时间，并加快了康復速度。诸如先进的血管成形术用气球、药物释放型球囊、动脉粥状硬化斑块切除术装置和专用支架等新型器械，正在拓展周边动脉疾病的治疗选择。这些创新技术具有更高的柔软性、输送性和疗效，使临床医生能够更有效地治疗复杂病变。此外，这些微创手术在维持正常血管解剖结构的同时，也提高了血管的长期通畅率，从而改善了整体治疗效果。周边动脉疾病市场的趋势表明，治疗方案正朝着更先进、更人性化的方向发展，这推动了对能够改善周边动脉疾病患者临床疗效和生活品质的创新器材的需求。根据美国心臟学会 (ACC) 估计，截至 2024 年 10 月，周边动脉疾病将影响全球 2 亿多人，其中 50 岁以上成年人的盛行率为 10% 至 15%。

人们生活水准的变化

周边动脉疾病）是糖尿病、肥胖、周边动脉疾病和吸烟等生活型态相关因素族群面临的主要健康问题。这些疾病在全球范围内的盛行率不断上升，尤其是在老龄化人群中，使得更多人面临患病风险。研究表明，到2024年，糖尿病患者罹患周边动脉疾病的风险将是一般人群的3至4倍。肥胖、高血压和吸烟的增加是导致盛行率上升的主要原因。糖尿病会导致动脉粥状硬化，使动脉狭窄，损害血液流动并最终导致周边动脉疾病。因此，对血管成形术、支架置入术和搭桥手术等诊断工具和治疗方法的需求日益增长。

人口老化的过程

全球人口老化周边动脉疾病市场带来了有利前景。由于血管老龄化增长而发生的变化以及动脉粥状硬化，老年人罹患周边动脉疾病的风险显着增加。产业报告预测，到2030年，全球60岁及以上人口将达到14亿，而老年人尤其容易受到与老龄化相关的动脉粥样硬化变化的影响，导致周边动脉狭窄或阻塞。随着老龄化，动脉弹性自然下降，可能导致动脉狭窄或阻塞，而这正是周边动脉疾病的特征。这种人口结构的变化正在推动对医疗保健服务的需求，包括诊断、预防性治疗以及微创介入治疗，例如血管成形术和支架植入术。因此，医疗保健机构正致力于满足老年患者的需求，因为他们通常患有多种复杂的疾病，这也促进了市场成长。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章执行摘要

第四章：引言

第五章：全球周边动脉疾病市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依类型

  • 週边血管生成球囊
  • 末梢用支架
  • 週边导管
  • 下腔静脉（IVC）滤器
  • 斑块修饰装置
  • 血流动力学控制装置
  • 周边设备

第七章 市场区隔：依最终用户划分

  • 医院
  • 专科诊所
  • 其他的

第八章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章 SWOT 分析

第十章：价值链分析

第十一章：波特五力分析

第十二章：价格分析

第十三章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Abbott Laboratories
    • AngioDynamics
    • B. Braun Melsungen AG
    • Becton Dickinson and Company
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Cardinal Health Inc.
    • Cook Medical LLC
    • Koninklijke Philips NV
    • Medtronic plc
    • Terumo Corporation
Product Code: SR112026A5822

The global peripheral artery disease market size was valued at USD 5.1 Billion in 2025. The market is projected to reach USD 7.9 Billion by 2034, exhibiting a CAGR of 4.78% from 2026-2034. North America currently dominates the market, holding a market share of 39.1% in 2025. At present, rising geriatric population, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, and improvements in healthcare infrastructure are propelling the market growth. Besides this, changing living standards of individuals are contributing to the expansion of the peripheral artery disease market share.

At present, the market is growing because of the increasing prevalence of chronic health ailments, including diabetes, and high cholesterol, which greatly elevate the risk of peripheral artery disease. An increasing elderly demographic is also fueling the market expansion, since senior individuals are more susceptible to circulatory issues. High awareness among patients and healthcare providers is resulting in prompt diagnosis and timely therapy. In addition, innovations in diagnostic imaging and minimally invasive techniques enhance treatment results and motivate more patients to pursue care. The development of novel medication treatments is further enhancing disease management and symptom regulation. Rising healthcare spending and enhanced access to medical services in both urban and rural areas are strengthening the peripheral artery disease market growth.

The United States has emerged as a major region in the peripheral artery disease market owing to many factors. The market is growing steadily due to the high prevalence of lifestyle-related diseases like diabetes, obesity, high blood pressure, and smoking, significantly contributing to the development of peripheral artery disease. As per the US Centers for Disease Control and Prevention (CDC), the percentage of obesity among adults in the US rose by 13.6% from 2010 to 2024. An aging population is increasing the number of individuals susceptible to vascular conditions, further driving the demand. The country has a strong healthcare infrastructure that supports early diagnosis, advanced imaging, and minimally invasive treatment options. Continuous advancements in drug development and medical devices improve treatment outcomes and reduce complications.

PERIPHERAL ARTERY DISEASE MARKET TRENDS:

Technological Advancements in Minimally Invasive Surgeries

The development of sophisticated catheter-based devices and techniques is revolutionizing vascular interventions, offering less invasive alternatives to traditional open surgeries. These advancements are significantly improving treatment outcomes by reducing patient discomfort, shortening hospital stays, and enabling faster recovery times. New devices, such as advanced angioplasty balloons, drug-coated balloons, atherectomy devices, and specialized stents, are expanding the range of treatment options available for peripheral artery disease. These innovations offer greater flexibility, deliverability, and efficacy, allowing clinicians to treat complex lesions more effectively. Furthermore, these less invasive procedures preserve normal vascular anatomy while improving long-term patency rates, leading to better overall outcomes. The peripheral artery disease market trends are showing a shift towards more advanced, patient-friendly treatment options, with increasing demand for innovative devices that enable better clinical results and improved quality of life for peripheral artery disease patients. The American College of Cardiology estimated that peripheral artery disease impacted over 200 Million individuals globally, affecting 10%-15% of adults aged over 50, as of October 2024.

Changing Living Standards of Individuals

People are suffering from peripheral artery disease due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As worldwide rates of these conditions are increasing, particularly in regions with aging populations, more individuals are at risk of peripheral artery disease. Studies indicated that in 2024, people with diabetes were 3 to 4 times more prone to developing peripheral artery disease. Rising rates of obesity, hypertension, and smoking contributed to the number of affected individuals. Diabetes leads to atherosclerosis, which narrows arteries and restricts blood flow, leading to peripheral artery disease. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is growing.

Increasing Aging Population

Rising aging population across the globe is offering a favorable peripheral artery disease market outlook. Older adults are facing a higher risk of developing peripheral artery disease owing to age-related vascular changes and atherosclerosis. As per industry reports, the worldwide population of individuals aged 60 and above is set to hit 1.4 Billion by 2030, and older adults are particularly susceptible to age-related atherosclerotic changes that narrow or block peripheral arteries. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of peripheral artery disease. This demographic shift is driving the demand for healthcare services, including diagnostics, preventive treatments, and minimally invasive interventions like angioplasty and stent placement. In line with this, healthcare providers are focusing on addressing the needs of elderly patients, who often have complex health profiles, thereby contributing to the market growth.

PERIPHERAL ARTERY DISEASE INDUSTRY SEGMENTATION:

Analysis by Type:

  • Peripheral Angioplasty Balloons
  • Peripheral Stents
  • Peripheral Catheters
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Peripheral Accessories

Peripheral stents held 22.8% of the market share in 2025. They offer an effective, minimally invasive solution for restoring blood flow in narrowed or blocked peripheral arteries. These stents are widely used to treat conditions, such as claudication and critical limb ischemia, which are common complications of peripheral artery disease. Peripheral stents help prevent artery collapse after angioplasty by keeping the blood vessels open, improving circulation and reducing symptoms like pain and fatigue. Their use results in quicker recovery times, lower risk of complications, and fewer repeat procedures compared to traditional surgical interventions. Technological advancements, such as drug-eluting stents and bioresorbable materials, are further enhancing their performance and expanding their adoption among physicians. As per the peripheral artery disease market forecast, the growing preferences for non-surgical treatments will continue to drive the demand for stents.

Analysis by End User:

  • Hospitals
  • Specialty Clinics
  • Others

Hospitals hold a significant share in the market based on end user because they offer comprehensive diagnostic and treatment facilities under one roof. Patients with peripheral artery disease often require advanced imaging, surgical interventions, and continuous monitoring, which hospitals are well-equipped to provide. Hospitals also have specialized vascular departments, experienced medical professionals, and access to the latest technologies. Emergency care and complex procedures, such as stent placements and bypass surgeries, are usually handled in hospitals.

Specialty clinics focus on outpatient care, early diagnosis, and minimally invasive treatments. These clinics often offer faster services, shorter wait times, and personalized care compared to large hospital settings. Patients with milder symptoms or those requiring routine follow-ups prefer specialty clinics for convenience. They are also equipped with modern diagnostic tools and employ vascular specialists who manage peripheral artery disease with targeted therapies.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America, accounting for a share of 39.1%, enjoys the leading position in the market. The region is experiencing high prevalence of lifestyle-related diseases, such as diabetes and smoking, which is contributing to the development of peripheral artery disease. The region has a well-established healthcare infrastructure that supports early diagnosis, advanced treatment options, and widespread access to care. There is also strong awareness among patients and healthcare providers about the symptoms and long-term complications of peripheral artery disease, leading to timely medical intervention. Continuous advancements in medical technologies, including imaging systems, drug therapies, and minimally invasive procedures, are further driving treatment adoption. In addition, high expenditure on research and development (R&D) activities by key industry players is leading to the creation of innovative solutions. Supportive reimbursement policies and government health programs are also encouraging routine screenings and preventive care. With a large patient population, expansion of hospitals, and access to cutting-edge treatments, North America continues to dominate the market in both value and innovation. As per the American Hospital Association, the United States had 6,093 hospitals in the beginning of 2025.

KEY REGIONAL TAKEAWAYS:

UNITED STATES PERIPHERAL ARTERY DISEASE MARKET ANALYSIS

The United States peripheral artery disease market holds a share of 89.10% in the North American region. It is expanding due to a significant rise in lifestyle-related conditions, such as obesity and high cholesterol. Increased government focus on early cardiovascular screening programs is also fostering early diagnosis, leading to timely interventions. According to the CDC, as of October 2024, six out of every ten Americans suffered from a chronic illness, while four out of ten faced two or more, highlighting the significant need for vascular treatment. Furthermore, the integration of artificial intelligence (AI) into vascular imaging and diagnostic platforms is enhancing clinical outcomes and decision-making precision. Technological innovations in minimally invasive endovascular therapies are being favored by healthcare providers and patients, accelerating procedural volume. The growing utilization of wearable health monitoring devices is further supporting continuous patient tracking and preventative care strategies. Additionally, heightened awareness about peripheral vascular health through national health initiatives and collaborations with healthcare professionals is strengthening the market landscape. Investment in outpatient care facilities that offer vascular services is also on the rise, providing more accessible care. With a robust infrastructure supporting clinical research and patient trials, the US continues to be at the forefront of peripheral artery disease therapy development.

EUROPE PERIPHERAL ARTERY DISEASE MARKET ANALYSIS

The Europe peripheral artery disease market is benefiting from an aging population and the growing emphasis on geriatric care services. Increased availability of vascular diagnostic tools in public healthcare systems is improving peripheral artery disease detection at earlier stages. Reports indicate that by 2050, 40.6% of the EU-27 population will be 55 years or older, resulting in a significant number of people at higher risk for peripheral artery disease. A surge in cross-border research collaborations within the European Union is promoting the development of innovative vascular health solutions tailored to diverse populations. Furthermore, clinical adoption of drug-eluting technologies and hybrid revascularization procedures is driving procedural efficiency across hospital settings. The rise of value-based healthcare initiatives is motivating healthcare systems to invest in long-term disease management programs, including peripheral artery disease. Preventative care is being reinforced through mobile health clinics and regional cardiovascular screening events, especially in underserved areas. Additionally, digital therapeutics tailored to vascular rehabilitation are being introduced, facilitating remote patient engagement and follow-up care.

ASIA-PACIFIC PERIPHERAL ARTERY DISEASE MARKET ANALYSIS

The Asia-Pacific peripheral artery disease market is witnessing notable growth due to a surge in urbanization activities and sedentary lifestyles. The expansion of universal health coverage schemes across several nations is driving the demand for standardized peripheral artery disease diagnostics and treatment. As per industry reports, between 2025 and 2050, crude cardiovascular mortality in Asia is set to increase by 91.2%, which is significantly influencing early screening and disease management efforts. There is a strong transition towards capacity-building programs to train healthcare workers in vascular care, which is improving diagnostic accuracy and treatment accessibility. Additionally, regional production of cost-effective stents and catheters is supporting broader adoption of endovascular procedures across tier II and III cities. Mobile telemedicine units and AI-oriented vascular screening tools are gaining traction in remote areas, enhancing patient outreach. These developments are shaping a rapidly evolving and inclusive market landscape across the region.

LATIN AMERICA PERIPHERAL ARTERY DISEASE MARKET ANALYSIS

The Latin American peripheral artery disease market is progressing steadily, supported by expanding public health infrastructure and the growing awareness about vascular health risks. A recent report highlighted that Brazil's funding for its Unified Health System was set to increase by 6.2% relative to 2024, indicating heightened national investments in both preventive and interventional cardiovascular services. Rising participation in international clinical trials is bringing exposure to advanced treatment methodologies and best practices. The growth of private diagnostic centers that offer specialized vascular assessments is contributing to the earlier identification of peripheral artery disease cases. Furthermore, academic partnerships facilitate knowledge exchange and technology transfer, enhancing procedural quality and training. Moreover, regional health campaigns aimed at promoting preventative cardiovascular care are catalyzing the demand for peripheral artery disease-related services.

MIDDLE EAST AND AFRICA PERIPHERAL ARTERY DISEASE MARKET ANALYSIS

The Middle East and Africa peripheral artery disease market is experiencing gradual growth, driven by the ongoing shift towards preventive healthcare practices and increased funding in primary care infrastructure. According to the US-Saudi Business Council, in 2025, 5% of the population in Saudi Arabia will be 60 years old or older, with this number expected to grow notably by 2040, signaling a rising demand for vascular care services. Public health authorities are promoting cardiovascular wellness through community outreach and mobile diagnostic camps. The integration of point-of-care (POC) testing devices in rural clinics is enhancing early peripheral artery disease detection. The growing participation in healthcare technology exhibitions and training forums is encouraging the adoption of digital diagnostic tools. These regional advancements are contributing to a more structured and responsive peripheral artery disease care ecosystem.

COMPETITIVE LANDSCAPE:

Key players are developing advanced treatment options, improving diagnostic technologies, and expanding access to care. They are investing heavily in R&D activities to create innovative medical devices, drug therapies, and minimally invasive procedures that improve patient outcomes and reduce recovery time. These companies are also focusing on generating awareness among healthcare providers and patients through educational campaigns and training programs. By partnering with hospitals, clinics, and research institutions, key players help ensure the latest technologies are effectively used in clinical settings. They also support large-scale clinical trials to prove the safety and effectiveness of new treatments. In addition, their worldwide reach and distribution networks assist in making peripheral artery disease treatments available in both developed and emerging markets. For instance, in March 2025, Lupin released generic rivaroxaban 2.5 mg tablets in the US following the receipt of final FDA approval. The medication, a generic variant of Xarelto, was utilized to lower cardiovascular risks in individuals with peripheral artery disease and coronary artery disease.

The report provides a comprehensive analysis of the competitive landscape in the peripheral artery disease market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • AngioDynamics
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Terumo Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the peripheral artery disease market?

2. What is the future outlook of peripheral artery disease market?

3. What are the key factors driving the peripheral artery disease market?

4. Which region accounts for the largest peripheral artery disease market share?

5. Which are the leading companies in the global peripheral artery disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peripheral Artery Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Peripheral Angioplasty Balloons
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Peripheral Stents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Peripheral Catheters
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Inferior Vena Cava (IVC) Filters
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Plaque Modification Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hemodynamic Flow Alteration Devices
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Peripheral Accessories
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Specialty Clinics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Abbott Laboratories
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 AngioDynamics
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 B. Braun Melsungen AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Becton Dickinson and Company
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Biotronik SE & Co. KG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Boston Scientific Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Cardinal Health Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Cook Medical LLC
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 SWOT Analysis
    • 13.3.9 Koninklijke Philips N.V.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Medtronic plc
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Terumo Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Peripheral Artery Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Peripheral Artery Disease Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Peripheral Artery Disease Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Peripheral Artery Disease Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Peripheral Artery Disease Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Peripheral Artery Disease Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Peripheral Artery Disease (Peripheral Angioplasty Balloons) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Peripheral Artery Disease (Peripheral Stents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Peripheral Artery Disease (Peripheral Stents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Peripheral Artery Disease (Peripheral Catheters) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Peripheral Artery Disease (Peripheral Catheters) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Peripheral Artery Disease (Inferior Vena Cava (IVC) Filters) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Peripheral Artery Disease (Plaque Modification Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Peripheral Artery Disease (Plaque Modification Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Peripheral Artery Disease (Hemodynamic Flow Alteration Devices) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Peripheral Artery Disease (Peripheral Accessories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Peripheral Artery Disease (Peripheral Accessories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Peripheral Artery Disease (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Peripheral Artery Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Peripheral Artery Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Peripheral Artery Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Peripheral Artery Disease (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Peripheral Artery Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: North America: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: North America: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: United States: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: United States: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Canada: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Canada: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Asia-Pacific: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Asia-Pacific: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: China: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: China: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Japan: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Japan: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: India: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: India: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: South Korea: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: South Korea: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Australia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Australia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Indonesia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Indonesia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Germany: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Germany: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: France: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: France: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: United Kingdom: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: United Kingdom: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Italy: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Italy: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Spain: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Spain: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Russia: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Russia: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Latin America: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Latin America: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Brazil: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Brazil: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Mexico: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Mexico: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Middle East and Africa: Peripheral Artery Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Middle East and Africa: Peripheral Artery Disease Market: Breakup by Country (in %), 2025
  • Figure 75: Middle East and Africa: Peripheral Artery Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Global: Peripheral Artery Disease Industry: SWOT Analysis
  • Figure 77: Global: Peripheral Artery Disease Industry: Value Chain Analysis
  • Figure 78: Global: Peripheral Artery Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peripheral Artery Disease Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Peripheral Artery Disease Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Peripheral Artery Disease Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 4: Global: Peripheral Artery Disease Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Global: Peripheral Artery Disease Market: Competitive Structure
  • Table 6: Global: Peripheral Artery Disease Market: Key Players